Benoît Brethon
Impact in
- Hematology top 2%
- Acute Myeloid Leukemia Research
- Chronic Myeloid Leukemia Treatments
- Infectious Diseases top 5%
- Antifungal resistance and susceptibility
Papers in
-
- Acute Lymphoblastic Leukemia research 24
- Oncology 20
- CAR-T cell therapy research 11
- Co-authors
- André Baruchel (23 shared papers)Thierry Leblanc (11 shared papers)Emmanuel Raffoux (5 shared papers)Anne Auvrignon (7 shared papers)Guy Leverger (9 shared papers)Claude Preudhomme (3 shared papers)Francis Derouin (4 shared papers)Patricia Ribaud (4 shared papers)
In The Last Decade
Benoît Brethon
49 papers receiving 1.3k citations
Hit Papers
Peers
Comparison fields: 5 of 92
- Hematology 440
- Infectious Diseases 393
- Genetics 136
- Public Health, Environmental and Occupational Health 341
- Epidemiology 342
Countries citing papers authored by Benoît Brethon
This map shows the geographic impact of Benoît Brethon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Benoît Brethon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Benoît Brethon more than expected).
Fields of papers citing papers by Benoît Brethon
This network shows the impact of papers produced by Benoît Brethon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Benoît Brethon. The network helps show where Benoît Brethon may publish in the future.
Co-authors
The 25 scholars most cited alongside Benoît Brethon, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 54 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2006 | 256 | |
| 2 | 2006 | 122 | |
| 3 | 2011 | 103 | |
| 4 | Blinatumomab Added to Chemotherapy in Infant Lymphoblastic Leukemia Hit paper breakdown → | 2023 | 83 |
| 5 | 2009 | 63 | |
| 6 | 2017 | 61 | |
| 7 | 2006 | 52 | |
| 8 | 2011 | 52 | |
| 9 | 2003 | 46 | |
| 10 | 2010 | 43 | |
| 11 | 2012 | 37 | |
| 12 | 2022 | 36 | |
| 13 | 2008 | 31 | |
| 14 | 2008 | 29 | |
| 15 | 2013 | 29 | |
| 16 | 2018 | 26 | |
| 17 | 2020 | 25 | |
| 18 | 2006 | 22 | |
| 19 | 2020 | 22 | |
| 20 | 2014 | 19 |
About Benoît Brethon
Benoît Brethon is a scholar working on Public Health, Environmental and Occupational Health, Oncology, Hematology, Pediatrics, Perinatology and Child Health and Infectious Diseases, having authored 54 papers that have together received 1.3k indexed citations. Recurring topics across this work include Acute Lymphoblastic Leukemia research (24 papers), Acute Myeloid Leukemia Research (15 papers), CAR-T cell therapy research (11 papers), Childhood Cancer Survivors' Quality of Life (10 papers), Antifungal resistance and susceptibility (8 papers), Chronic Lymphocytic Leukemia Research (6 papers), Fungal Infections and Studies (6 papers) and Pneumocystis jirovecii pneumonia detection and treatment (5 papers). The work is most often cited by research in Hematology (440 citations), Infectious Diseases (393 citations), Genetics (136 citations), Public Health, Environmental and Occupational Health (341 citations) and Epidemiology (342 citations). Benoît Brethon has collaborated with scholars based in France, Germany and Italy. Frequent co-authors include André Baruchel, Thierry Leblanc, Emmanuel Raffoux, Anne Auvrignon, Guy Leverger, Claude Preudhomme, Francis Derouin, Patricia Ribaud, Annie Sulahian and Nicolas Boissel. Their work appears in journals such as Blood, British Journal of Haematology, Journal of Pediatric Hematology/Oncology, Haematologica and Journal of Clinical Microbiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.